HeartSciences Inc. filed an 8-K on May 28, 2025, to report the approval of 4,285,714 shares of Series D Convertible Preferred Stock at $3.50 each, linked to a $15 million offering. Each share can be converted into common stock at $5.00, and the preferred shares rank senior in payouts during liquidation.